We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
Cap. Flow
+$1.17B
Cap. Flow %
9.66%
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$197M
2
BABA icon
Alibaba
BABA
+$190M
3
AMZN icon
Amazon
AMZN
+$161M
4
GDDY icon
GoDaddy
GDDY
+$135M
5
DIS icon
Walt Disney
DIS
+$132M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$122M
2
ZTS icon
Zoetis
ZTS
+$96.3M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$69.5M
4
CDNS icon
Cadence Design Systems
CDNS
+$64.2M
5
ANSS
Ansys
ANSS
+$60.2M

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Consumer Discretionary 23.99%
3 Technology 11.1%
4 Financials 8.14%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRM icon
51
Salesforce
CRM
$155B
$40.8M 0.34%
269,022
+258,076
+2,358% +$40.4M
MRK icon
52
Merck
MRK
$324B
$38.9M 0.32%
486,554
+255,864
+111% +$19.6M
SBUX icon
53
Starbucks
SBUX
$118B
$38.9M 0.32%
463,439
-710,495
-61% -$55.7M
RJF icon
54
Raymond James Financial
RJF
$33.8B
$38.7M 0.32%
+686,558
New +$39.1M
CROX icon
55
Crocs
CROX
$6.63B
$38.5M 0.32%
1,946,842
+207,378
+12% +$4.8M
WHR icon
56
Whirlpool
WHR
$2.47B
$38.4M 0.32%
269,711
+236,514
+712% +$31.7M
HUM icon
57
Humana
HUM
$43.1B
$38M 0.31%
+143,319
New +$36.3M
REGN icon
58
Regeneron Pharmaceuticals
REGN
$73B
$37.9M 0.31%
+121,175
New +$40.3M
CFG icon
59
Citizens Financial Group
CFG
$30.5B
$37.8M 0.31%
1,069,886
+722,663
+208% +$25.2M
SPY icon
60
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$37.5M 0.31%
128,100
+100,500
+364% +$28.9M
UHS icon
61
Universal Health Services
UHS
$10.3B
$37.4M 0.31%
286,659
+72,169
+34% +$9.08M
KHC icon
62
Kraft Heinz
KHC
$33B
$36.9M 0.3%
+1,189,095
New +$37.5M
TAK icon
63
Takeda Pharmaceutical
TAK
$56.7B
$36.8M 0.3%
2,079,070
-885,137
-30% -$16.1M
ZAYO
64
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$35.7M 0.29%
1,084,385
+882,757
+438% +$28.2M
MCO icon
65
Moody's
MCO
$84.1B
$35.2M 0.29%
180,086
-142,422
-44% -$27M
MNRO icon
66
Monro
MNRO
$440M
$34.9M 0.29%
409,252
+320,167
+359% +$26.7M
NOC icon
67
Northrop Grumman
NOC
$77.4B
$34.6M 0.29%
107,231
+104,195
+3,432% +$31.1M
GRMN
68
Garmin
GRMN
$57.4B
$34.6M 0.28%
433,429
+373,808
+627% +$30.6M
SYY icon
69
Sysco
SYY
$41B
$34.5M 0.28%
487,428
+307,094
+170% +$21.9M
TLT icon
70
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.9B
$34.2M 0.28%
240,300
+205,900
+599% +$26.1M
CELG
71
DELISTED
Celgene Corp
CELG
$34.1M 0.28%
368,446
+165,055
+81% +$15.7M
APC
72
DELISTED
Anadarko Petroleum
APC
$33.8M 0.28%
479,558
+431,282
+893% +$28.9M
LHX icon
73
L3Harris
LHX
$55.7B
$33.4M 0.27%
176,648
+155,137
+721% +$28M
YUM icon
74
Yum! Brands
YUM
$41.9B
$32.7M 0.27%
295,876
-71,727
-20% -$7.45M
QGEN icon
75
Qiagen
QGEN
$8.66B
$32.2M 0.26%
746,710
+364,618
+95% +$15.1M
1 2
3
4 5

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.

  • Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
  • Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
  • Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
  • Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
  • Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.